🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSELECT trial: 20% MACE reduction — 6 month update Page 3

SELECT trial: 20% MACE reduction — 6 month update

Admin Tue, Sep 24, 2024 at 8:21 AM 11 replies 1,765 viewsPage 3 of 3
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Sep 30, 2024 at 1:43 PM#11
SarahChen_PharmD said:
Relative and absolute effects need reading together.

6 month update on cardiovascular risk: down 45 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

7 5FitDadDave, RunnerRach, TrialNerd_Beth and 4 others
Reply Quote Save Share Report
paul_denver
Member
723
3,234
May 2024
Denver, CO
Sep 30, 2024 at 3:55 PM#12
pam_columbus said:
Agreed, and subgroup analyses deserve particular suspicion.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

8 6jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 5 others
Reply Quote Save Share Report
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
Sep 30, 2024 at 6:07 PM#13
SarahChen_PharmD said:
Relative and absolute effects need reading together.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

9 7SallyK_inj, CryptoCarl, MariaRD and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Sep 30, 2024 at 8:19 PM#14
Admin said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

10 8SandraNC_45, Dr.EndoIndy, tom_AK and 7 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 30, 2024 at 10:31 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. Tagging this one for the weekly digest.

11 9PurityPaulOR, MaxMetOK, MounjBrad and 8 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register